Thought Leadership
Insight

The Future of eCOA and Wearable Devices

Electronic Clinical Outcome Assessment (eCOA) wearables have been a major player in the collection of large volumes of patient-reported data. With clinical research generating large and complex datasets at a rapid rate, the value of eCOAs is increasingly apparent, offering new...
Insight

The C3 Summit: Boston Recap

The second event in our series of C3 Summits took place in Boston on May 16, 2023. We invited industry experts and leaders to discuss challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments through the lens of real-world...
Webinar

LifeSci Talks COA Series | Harnessing Implementation Science to Improve Health Outcomes: Methods and Approaches for the Future

Implementation science emerged as a response to the recognition that many effective health interventions and innovations were not being widely adopted or sustained in practice, even when evidence of their efficacy was strong. Join Meredith Smith, Senior Director of Implementation...
Insight

How Medical Writing Can Drive Patient Engagement

Medical writing is a critical component of the broader patient engagement landscape, establishing the foundations of communication between pharmaceutical companies and patients. The quality of medical communication can be transformational in how a patient engages with and...
Webinar

A Conversation with Dr. Elin Haf Davies of Aparito

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder &...
Webinar

Navigating the EU Clinical Trial Regulation Complexities - Current Challenges and Opportunities

As the most significant change in the European Union clinical trial legislative ecosystem in 20 years, the European Union Clinical Trial Regulation 536/2014 (EU CTR) went live on January 31, 2022. The first-year transition period has now ended, and from January 31, 2023, EU...
Webinar

How to Maximise Value and Avoid Failure During Life Sciences Dealmaking

Please complete the form below to access the on-demand recording of our webinar. A fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices...
Insight

Centralizing Global Content Solutions for Medical Affairs

With a rapidly evolving landscape and the introduction of new technologies and emerging therapeutics, medical affairs professionals are tasked with remaining in lockstep with the latest industry developments. From a content perspective, this means not only maintaining clear lines...
Webinar

Automation for MDR & IVDR: A Three-Part Seminar - Part 3: EnCompass Step by Step: A Detailed View of the Content Automation Solution to Meet MDR & IVDR Requirements

Part 3: EnCompass Step by Step: A Detailed View of the Content Automation Solution to Meet MDR & IVDR Requirements...
Webinar

Automation for MDR & IVDR: A Three-Part Seminar - Part 2: Structured Content and CCMS Technology to meet MDR & IVDR requirements: Takeda Medical Device Group, Qserve, & TransPerfect Medical Device Solutions

Part 2: What is a CCMS and How Does It Address the Challenges Posed by MDR and IVDR?...
Webinar

Automation for MDR and IVDR: A Three-Part Seminar - Part 1: What Is a CCMS and How Does It Address the Challenges Posed by MDR and IVDR?

Part 1: What is a CCMS and How Does It Address the Challenges Posed by MDR and IVDR?...
Event Clinical Research C3

C3 Summit Princeton

| Join your industry peers for Conversations on Clinical Content, C3 Summit. Panels of pharma, biotech, CRO, and regulatory thought leaders will explore patient diversity, centricity, and outcome assessments, discussing challenges, opportunities, and strategies through the lens of...
Event Clinical Research C3

C3 Summit London

| Join your industry peers for Conversations on Clinical Content, C3 Summit. Panels of pharma, biotech, CRO, and regulatory thought leaders will explore patient diversity, centricity, and outcome assessments, discussing challenges, opportunities, and strategies through the lens of...
Event Clinical Research C3

C3 Summit Boston

| Join your industry peers for Conversations on Clinical Content, C3 Summit. Panels of pharma, biotech, CRO, and regulatory thought leaders will explore patient diversity, centricity, and outcome assessments, discussing challenges, opportunities, and strategies through the lens of...
Insight

The C3 Summit: San Francisco Recap

April 20 marked the first in our series of C3 Summits, which kicked off in San Francisco. Throughout the event, we invited industry experts to panel discussions to explore patient diversity, centricity, clinical technologies, and innovations. In this recap, we will...
Insight

Overcoming 5 Challenges of Implementing eClinical Technologies

eClinical technology has transformed the clinical trial landscape, maximized data collection efficiency, and streamlined trial operations. Innovations in this space, such as electronic trial master files (eTMF), clinical trial management systems (CTMS), and electronic...
Client Story

Panel: Deploying AI for Translation - Real Life Examples

Learn how leading companies deploy machine translation and the results they are seeing from their MT strategy. ...
Insight

Centralizing Global Content Solutions for Patient Engagement Teams

Patient welfare and engagement are central to an effective healthcare system, and engagement teams play a vital role in ensuring that patients receive the best care possible. In fact, a study conducted by the American Journal of Managed Care found that patients who are directly...
Insight

What Are Unitary Patents and What Do They Mean for Life Sciences Companies?

A Unitary Patent (UP) is a new system for patent protection in the EU that aims to simplify the complex and costly validation and translation requirements. The initiative is expected to have a significant impact on life sciences organizations in the EU by reducing costs,...
Insight

The Quality Review of Documents (QRD) v9.0 for Veterinarians: A Step Toward Better Care

The Quality Review of Documents (QRD V9) update came into effect on January 28, 2022. The new version consists of a set of guidelines established by the European Medicines Agency (EMA) outlining the responsibilities and duties of those who ensure the quality of veterinary...
Insight

Leveraging Social Media for Patient Recruitment in Clinical Trials

Identifying and connecting with prospective patients for clinical trials via social media and digital channels presents several challenges due to regulations that restrict patient communications. For example, the FDA has issued guidelines on the use of social media in patient...
Insight

International Women's Day: Embracing Equity in Life Sciences

International Women's Day is celebrated annually on March 8 to recognize the social, economic, cultural, and political achievements of women worldwide. The theme for International Women's Day 2023 is "Embrace Equity." Promoting gender equity across life sciences is essential to...
Event Clinical Research C3

C3 Summit San Francisco

| Join your industry peers for Conversations on Clinical Content, C3 Summit. Panels of pharma, biotech, CRO, and regulatory thought leaders will explore patient diversity, centricity, and outcome assessments, discussing challenges, opportunities, and strategies through the lens of...
Insight

IMP Labeling: EU CTR Transition Considerations

The European Union Clinical Trial Regulation (EU CTR) went live on January 31, 2022. The first-year transition period ended on January 30, 2023, so using the Clinical Trial Information System (CTIS) is now mandatory for all initial submissions of interventional clinical trials...